Microbial aetiology of brain abscess in a UK cohort: Prominent role of Streptococcus intermedius



Darlow, Christopher A ORCID: 0000-0002-5400-3413, McGlashan, Nicholas, Kerr, Richard, Oakley, Sarah, Pretorius, Pieter, Jones, Nicola and Matthews, Philippa C
(2020) Microbial aetiology of brain abscess in a UK cohort: Prominent role of Streptococcus intermedius. JOURNAL OF INFECTION, 80 (6). pp. 623-629.

[img] Text
Microbial aetiology of brain abscess in a UK cohort Prominent role of Streptococcus intermedius.pdf - Published version

Download (916kB) | Preview

Abstract

<h4>Background</h4>Brain abscess is an uncommon condition, but carries high mortality. Current treatment guidelines are based on limited data. Surveillance of clinical, radiological and microbiology data is important to inform patient stratification, interventions, and antimicrobial stewardship.<h4>Methods</h4>We undertook a retrospective, observational study of patients with brain abscess, based on hospital coding, in a UK tertiary referral teaching hospital. We reviewed imaging data, laboratory microbiology, and antibiotic prescriptions.<h4>Results</h4>Over a 47 month period, we identified 47 adults with bacterial brain abscess (77% male, median age 47 years). Most of the abscesses were solitary frontal or parietal lesions. A microbiological diagnosis was secured in 39/47 (83%) of cases, among which the majority were of the Streptococcus milleri group (27/39; 69%), with a predominance of Streptococcus intermedius (19/27; 70%). Patients received a median of 6 weeks of intravenous antibiotics (most commonly ceftriaxone), with variable oral follow-on regimens. Ten patients (21%) died, up to 146 days after diagnosis. Mortality was significantly associated with increasing age, multiple abscesses, immunosuppression and the presence of an underlying cardiac anomaly.<h4>Conclusion</h4>Our data suggest that there has been a shift away from staphylococcal brain abscesses, towards S. intermedius as a dominant pathogen. In our setting, empiric current first line therapy with ceftriaxone remains appropriate on microbiological grounds and narrower spectrum therapy may sometimes be justified. Mortality of this condition remains high among patients with comorbidity. Prospective studies are required to inform optimum dose, route and duration of antimicrobial therapy.

Item Type: Article
Uncontrolled Keywords: Brain abscess, Aetiology, Microbiology, Epidemiology, Prevalence, Streptococci, Streptococcus milleri, Imaging, antibiotics
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 08 Sep 2021 09:30
Last Modified: 18 Jan 2023 21:29
DOI: 10.1016/j.jinf.2020.03.011
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3136356